Naltrexone Promotes Weight Loss in Women With Schizophrenia

Patients with schizophrenia experience higher rates of obesity as well as related morbidity and mortality than the general population does. Women with schizophrenia are at particular risk for antipsychotic-associated weight gain, obesity, and related medical disorders such as diabetes and cardiovascular disease.

READ FULL ARTICLE Curated publisher From Lww